Fisher & Paykel Healthcare Corporation Limited

ASX:FPH ISIN:NZFAPE0001S2

The company designs, manufactures and markets heated humidification products and systems for use in respiratory care and the treatment of obstructive apnea. Its products and systems are sold in over 90 countries worldwide. 
 
     

查看其它語言版本

新聞

11月19日澳洲股市:市場在尋找新的方向

🕔11/19/2009 1:00:20 PM 16493

在一份令人失望的報告顯示美國10月份的住房開工數下降了10.6%、批准數下降了4.0%之後,昨晚華爾街結束了連日的上漲,收市下跌。這次下挫顯示房地產行業仍承受著壓力。

閱讀全文
###

71,762 公司背景瀏覽

  • 本頁瀏覽人次: (過去7日: 28) (過去30日: 114) (自發布以來: 10272) 

公司詳細

    傳真
  • +64 9 574 0158 
  • 主要部門
  • 醫療-製藥 
  • 支柱產業
  • 保健 
  • 主頁
  • www.fphcare.co.nz

更多新聞紀錄

  • 2025/03/06: FPH enters into construction contract for fifth NZ building*
  • 2025/03/04: Ceasing to be a substantial holder*
  • 2025/02/28: Ceasing to be a substantial holder*
  • 2025/02/21: Ongoing Disclosure Notice - Ordinary Shares*
  • 2025/02/17: Change in substantial holding*
  • 2025/02/04: Notification of cessation of securities - FPH*
  • 2025/02/03: Costs forecast to increase under new US tariff regime*
  • 2025/01/06: Application for quotation of securities - FPH*
  • 2024/12/19: Notification of cessation of securities - FPH*
  • 2024/12/13: Update - Dividend/Distribution - FPH*
*refer to company website